(Total Views: 868)
Posted On: 11/24/2020 3:11:25 PM
Post# of 145882
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Merck (MRK) said Monday 23 nov 2020 it plans to acquire privately held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that has shown striking results in hospitalized patients with Covid. The treatment was shown to reduce the risk of respiratory failure or death by more than 50% in patients hospitalized with Covid and requiring oxygen. (CNBC)
DOES ANYONE KNOW THIS DRUG??
DOES ANYONE KNOW THIS DRUG??
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)